References
- Aula P, Autio S, Raivio K O, Rapola J. Aspartyl-glucosaminuria. Genetic errors of glycoprotein metabolism, P Durant, J S O'Brien. Springer-Verlag, Berlin 1982; 123–52
- Aronson N N, Kuranda J K. Lysosomal degradation of Asn-linked glycoproteins. FASEB J 1989; 3: 2615–22
- Pollitt R J, Pretty K M. The glycoasparagines in urine of a patient with aspartylglucosaminuria. Biochem J 1974; 141: 141–6
- Maury C PJ. Accumulation of two glycoasparagines in the liver in aspartylglucosaminuria. J Biol Chem 1979; 254: 1513–5
- Kaartinen V, Mononen I. Analysis of aspartylgluco-samine at the picomole level by high-performance liquid chromatography. J Chromatogr 1989; 490: 292–9
- Aula P, Autio S, Raivio K O, Näntö V. Detection of heterozygotes for aspartylglucosaminuria (AGU) in cultured fibroblasts. Humangenetik 1974; 25: 307–14
- Aula P, Raivio K O, Autio S. Enzymatic diagnosis and carrier detection of aspartylglucosaminuria using blood samples. Pediatr Res 1976; 10: 625–9
- Autio S. Aspartylglucosaminuria. Analysis of thirty-four patients. J Ment Defic Res Monogr Ser I 1972
- Borud O, Torp K H, Dahl T. Aspartylglucosaminuria. Urinary excretion of aspartylglucosamines related to mental retardation. Hum Genet Monogr 1978; 10: 23–6
- Pollitt R J, Jenner F A, Merskey H. Aspartylglucosaminuria. An inborn error of metabolism associated with mental defect. Lancet 1968; 2: 253–5
- Baumann M, Peltonen L, Aula P, Kalkkinen N. Isolation of a human hepatic 60 kDa aspartyl-glucosaminidase. Biochem J 1989; 262: 189–94
- Ikonen E, Baumann M, Grön K, Syvänen A-C, Enomaa N, Halila R, Aula P, Peltonen L. Aspartylglucosaminuria: cDNA encoding human aspartylglucosaminidase and the missense mutation causing the disease. EMBO J 1991a; 10: 51–8
- Fisher K J, Tollersrud O K, Aronson N N. Cloning and sequence analysis for human glycosyl-asparaginase. FEBS Lett 1990; 269: 440–4
- Halila R, Baumann M, Ikonen E, Enomaa N, Peltonen L. Human leucocyte aspartylglucosaminidase. Evidence for two different subunits in a more complex native structure. Biochem J 1991; 276: 251–6
- Tollersrud O K, Aronson N N. (1992) Comparison of liver glycosylasparaginases from six vertebrates. Biochem J 1992; 282: 891–7
- Enomaa N, Heiskanen T, Halila R, Sormunen R, Seppälä R, Vihinen M, Peltonen L. Human aspartylglucosaminidase: a biological and immuno-cytochemical characterization of the enzyme in normal and aspartylglucosaminuria fibroblasts. Biochem J 1992; 286: 613–8
- Mononen I, Heisterkamp N, Kaartinen V, Williams J C, Yates J R, Griffin P R, Hood L E, Groffen J. Aspartylglucosaminuria in the Finnish population. Identification of two point mutations in the heavy chain of glycoasparaginase. Proc Natl Acad Sci USA 1991; 88: 2941–5
- Fisher K J, Aronson N N. Characterization of the mutation responsible for aspartylglucosaminuria in three Finnish patients. J Biol Chem 1991; 266: 12105–13
- Syvänen A-C, Ikonen E, Manninen T, Bengtström M, Söderlund H, Aula P, Peltonen L. Convenient and quantitative determination of the frequency of a mutant allele using solid-phase minisequencing: Application to aspartylglucosaminuria in Finland. Genomics 1992; 12: 590–5
- Ikonen E, Enomaa N, Ulmanen I, Peltonen L. In vitro mutagenesis helps to unravel the biological consequences of aspartylglucosaminuria mutation. Genomics 1991c; 11: 206–11
- Syvanen A-C, Aalto-Setälä K, Harju L, Konrula K, Söderlund H. A primer-guided nucleotide incorporation assay in the genotyping of apolipoprotein E. Genomics 1990; 8: 684–92
- Ikonen E, Aula P, Grön K, Tollersrud O, Halila R, Manninen T, Syvänen A-C, Peltonen L. Spectrum of mutations in aspartylglucosaminuria. Proc Natl Acad Sci USA 1991b; 88: 11222–6
- Ikonen E, Ulmanen I, Peltonen L. Deletion of the 3′-untranslated region of aspartylglucosaminidase mRNA results in a lysosomal accumulation disease. J Biol Chem 1992; 267: 8715–8